Skip to main content
Fig. 1 | European Journal of Medical Research

Fig. 1

From: Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case–control study

Fig. 1

Boxplots of observed concentrations of pyrimethamine (a) and sulfadiazine (b) versus time during the early treatment phase in female patients with acute ocular toxoplasmosis (OT). Red lines: lower and upper target concentrations of pyrimethamine (700 and 1300 µg/l)14 and sulfadiazine (50 and 150 mg/l)21

Back to article page